2026-03-13 Investor Notice Regarding Revision of Full-Year Financial Results Forecast for the Fiscal Year Ending July 2026 2026-03-13 Investor [Summary]Consolidated Financial Results for the Six Months Ended January 31, 2026 (Based on Japanese GAAP) 2026-02-16 Investor Notice Concerning Dividends of Surplus (Interim Dividend) 2025-12-11 Investor Supplementary Materials of Consolidated Financial Results for the Three Months Ended October 31 2025 2025-12-11 Investor [Summary]Consolidated Financial Results for the Three Months Ended October 31, 2025 (Under Japanese GAAP) 2025-11-17 Investor Notice Regarding the Disposal of Treasury Shares as Restricted Stock Compensation 2025-11-13 Research and Development Pharma Foods Partners with The University of Tokyo For Next-Generation Antibody Drug Discovery ～A Leap Forward with AI and Advanced Molecular Engineering～ 2025-09-30 Investor Notice of the 28th Annual General Meeting of Shareholders 2025-09-25 Investor Consolidated Financial Results for the Year Ended July 31, 2025 (Based on Japanese GAAP) 2025-09-24 Research and Development “ALAgene® technology”-Derived Antibody Therapeutic Candidate Achieves Phase I Clinical Milestone ～Driving Future Growth through Strategic License Agreement～ More